Will BAH achieve FY2026 adjusted diluted EPS at or above $5.95 (low end of raised guidance)?
Current Prediction
Why This Question Matters
Management raised ADEPS guidance to $5.95-$6.15 in Q3 despite lowering revenue guidance twice -- testing whether cost restructuring ($150M annualized) translates to earnings execution. Achieving $5.95+ validates that BAH can protect profitability during revenue headwinds. Missing the bottom end would undermine the MEETING operational execution assessment.
Prediction Distribution
Individual Predictions(9 runs)
Q1-Q3 ADEPS of $4.74 requires only $1.21 in Q4 to reach $5.95. Q3 delivered $1.77 -- significantly above the needed run-rate. Even accounting for Q4 seasonality (historically weaker), the Q2 ADEPS of $1.49 and Q1 of $1.48 both exceed the $1.21 threshold. The cost restructuring ($150M annualized) executed in Q3 with full impact beginning FY2027 should provide at least modest Q4 benefit. Management raised this guidance after two revenue cuts -- they would not raise EPS guidance without high confidence in delivery.
The $5.95 threshold is the LOW end of raised guidance ($5.95-$6.15). Management raised this guidance at Q3 -- the latest data point before Q4 -- with full visibility into Q4 run-rate. Government contractors rarely miss their own raised guidance by the low end within the same quarter. The $487M in share buybacks at declining prices ($95-110 range) provides mechanical EPS support through share count reduction. Even a weak Q4 revenue quarter should produce $1.21+ ADEPS given cost restructuring.
Key risks to missing $5.95: (1) one-time restructuring charges not excluded from adjusted figures, (2) government shutdown Q4 revenue impact beyond the estimated $50M/$20M, (3) accelerating revenue decline compressing margins faster than cost cuts offset. However, the adjusted EPS metric typically excludes restructuring charges, and the shutdown impact was estimated and likely incorporated into raised guidance. The buffer of $0.56 ($1.77 Q3 vs $1.21 needed) provides substantial cushion.
The math strongly favors hitting $5.95: $4.74 through Q3 with Q3 showing $1.77 (strongest quarter). Q4 needs $1.21 -- lowest quarter requirement. Even if Q4 is the weakest quarter of the year, the $1.21 bar is achievable given Q1-Q2 both delivered $1.48-$1.49. Cost restructuring benefits and buyback-driven share count reduction provide additional support. Very high probability of achieving low end.
The main risk is an unexpected one-time charge in Q4 that depresses adjusted EPS. However, management explicitly raised guidance in Q3, knowing Q4 conditions. The government shutdown impact was already estimated and presumably factored in. BAH management has a track record of meeting guidance commitments. The $0.56 buffer from Q3 to Q4 needed is very large -- even a 30% sequential decline from Q3 would produce $1.24 ADEPS, still above threshold.
Management would not raise EPS guidance after two revenue cuts unless they had very high confidence. The raise from $5.45-$5.65 to $5.95-$6.15 represents a $0.50 increase at both ends -- a significant upward revision during a challenging year. This level of conviction, combined with Q3 execution at $1.77, makes missing the $5.95 floor very unlikely barring an extraordinary negative event.
$4.74 through Q3. Only $1.21 needed in Q4. Q3 delivered $1.77. Management raised guidance. Cost cuts provide tailwind. Very high probability.
Strong buffer from Q3 delivery. Management raised guidance -- signals confidence. Buybacks reduce share count. Main risk is unexpected charges. High probability.
Math heavily favors YES. $1.21 Q4 needed vs $1.77 Q3 delivered. Even worst Q4 scenario should exceed $1.21 given cost restructuring and share count reduction. High probability.
Resolution Criteria
Resolves YES if BAH reports FY2026 full-year adjusted diluted EPS of $5.95 or higher. Resolves NO if FY2026 ADEPS is below $5.95.
Resolution Source
BAH FY2026 Q4/full-year earnings release
Source Trigger
FY2026 ADEPS guidance raised to $5.95-$6.15 despite revenue headwinds. Tests whether cost restructuring translates to earnings execution.
Full multi-lens equity analysis